Recon: Novo’s Wegovy nabs FDA approval for higher dose under CNPV program; FDA authorizes J&J’s oral psoriasis drug

• National survey of NIH-funded researchers shows precarious state of U.S. science — ‘This is like the Titanic’ (STAT)
• US FDA approves higher dose of Wegovy (Reuters)
• Senate Democrats lay out plans to overhaul health insurance after setbacks under Trump (STAT)
• There is a successor to 340B lurking on the horizon (STAT)
• As Trump administration cracks down on health care fraud, people with disabilities feel singled out (STAT)
• Four major drugmakers will face revived case over 340B prices (Endpoints)

• AstraZeneca deepens UK-China ties with cell therapy R&D hub, manufacturing plans (Endpoints)
• House lawmakers signal willingness to counter China’s biotech gains (Endpoints)
• UK health official says too soon to declare Kent meningitis outbreak contained (Reuters)
• Amplifon Buys GN Hearing For €2.3Bn, Taking Aim At Sonova And Demant (MedTech Insight)
• Injuries, Death, Linked To Intuitive Surgical Stapler Used With Da Vinci Robotic System (MedTech Insight)

• Eli Lilly’s ‘triple-G’ drug leads to significant blood sugar, weight reductions in diabetes trial (STAT)
• Clearing tumors in mice, Azalea Therapeutics advances dream of in vivo CAR-T therapy (STAT)
• How ARPA-H is developing FDA-authorized AI agents, tested in clinical trials (STAT)
• A Huntington’s researcher on the UniQure-FDA fray (STAT)
• Pfizer seeks earlier use of Talzenna in prostate cancer with Phase 3 win (Endpoints)
• Collegium is acquiring Corium's approved ADHD drug for $650M (Endpoints)
• Washington’s Medicaid program will pay for ElliQ, an AI robot for loneliness (Endpoints)
• Updated: Lilly’s triple-G comparable with Mounjaro, first Phase 3 diabetes data suggest (Endpoints)
• Exclusive: Congruence raises $40M, enters clinic with lead obesity drug (Endpoints)
• Exclusive: Specialty care network company Lantern raises $30M (Endpoints)
• US FDA approves J&J's oral psoriasis pill (Reuters)
• After Alfasigma's GSK licensing deal, Lynavoy picks up FDA nod in rare liver disease (Fierce Pharma)

• Intuitive Surgical recalls stapler reloads over issue linked to patient death (MedTech Dive)
• MiniMed gets FDA nod for smaller insulin pump (MedTech Dive)
• JenaValve snags FDA approval in aortic regurgitation (MedTech Dive)
• Cognito Shows Off More Positive Data For Device-Based Alzheimer’s Treatment (MedTech Insight)
• JenaValve’s Trilogy Becomes First FDA-Approved TAVR Treatment For Aortic Regurgitation (MedTech Insight)

• ECDC renews Cape Verde warning as illnesses continue (Food Safety News)
• FDA continues investigation of outbreaks (Food Safety News)

• HHS watchdog slams nursing homes’ antipsychotic drug use and schizophrenia diagnoses (STAT)
• A Maryland legislator wants pharma and patient groups to disclose ties to disease awareness campaigns (STAT)
• How a Texas couple is getting rich off out-of-network medical bills (STAT)